 | • レポートコード：GIR201111783 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、遺伝性血管浮腫治療の世界市場を調査対象にし、遺伝性血管浮腫治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（C1 エステラーゼ阻害剤（血漿製品、組換え製品）、選択的ブラジキニンB2受容体拮抗薬（Firazyr）、カリクレイン阻害剤（Kalbitor、Takhzyro）、その他（従来薬、パイプライン薬））、用途別分析（病院薬局、小売薬局、その他（オンライン薬局、郵便薬局））、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：CSL、Ionis Pharmaceuticals、Pharming Group、KalVista Pharmaceuticals、Shire plc (Takeda Pharmaceutical Company Limited)、BioCryst Pharmaceuticals、Attune Pharmaceuticals ・メーカー別販売量、売上、市場シェア ・遺伝性血管浮腫治療の地域別市場分析 ・遺伝性血管浮腫治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・遺伝性血管浮腫治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・遺伝性血管浮腫治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・遺伝性血管浮腫治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・遺伝性血管浮腫治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・遺伝性血管浮腫治療の種類別市場規模2015-2020：C1 エステラーゼ阻害剤（血漿製品、組換え製品）、選択的ブラジキニンB2受容体拮抗薬（Firazyr）、カリクレイン阻害剤（Kalbitor、Takhzyro）、その他（従来薬、パイプライン薬） ・遺伝性血管浮腫治療の用途別市場規模2015-2020：病院薬局、小売薬局、その他（オンライン薬局、郵便薬局） ・遺伝性血管浮腫治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Hereditary Angioedema Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Hereditary Angioedema Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Hereditary Angioedema Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hereditary Angioedema Treatment market has been segmented into
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
By Application, Hereditary Angioedema Treatment has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hereditary Angioedema Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Hereditary Angioedema Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hereditary Angioedema Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Hereditary Angioedema Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Hereditary Angioedema Treatment Market Share Analysis
Hereditary Angioedema Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hereditary Angioedema Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hereditary Angioedema Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Hereditary Angioedema Treatment are:
CSL
Ionis Pharmaceuticals
Pharming Group
KalVista Pharmaceuticals
Shire plc (Takeda Pharmaceutical Company Limited)
BioCryst Pharmaceuticals
Attune Pharmaceuticals
Among other players domestic and global, Hereditary Angioedema Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hereditary Angioedema Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hereditary Angioedema Treatment, with price, sales, revenue and global market share of Hereditary Angioedema Treatment in 2018 and 2019.
Chapter 3, the Hereditary Angioedema Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hereditary Angioedema Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Hereditary Angioedema Treatment market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Hereditary Angioedema Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Hereditary Angioedema Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hereditary Angioedema Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
1.2.5 Others (Conventional Drugs, Pipeline Drugs)
1.3 Market Analysis by Application
1.3.1 Overview: Global Hereditary Angioedema Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others (online pharmacies, mail pharmacies)
1.4 Overview of Global Hereditary Angioedema Treatment Market
1.4.1 Global Hereditary Angioedema Treatment Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CSL SWOT Analysis
2.1.4 CSL Product and Services
2.1.5 CSL Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ionis Pharmaceuticals
2.2.1 Ionis Pharmaceuticals Details
2.2.2 Ionis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ionis Pharmaceuticals SWOT Analysis
2.2.4 Ionis Pharmaceuticals Product and Services
2.2.5 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pharming Group
2.3.1 Pharming Group Details
2.3.2 Pharming Group Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pharming Group SWOT Analysis
2.3.4 Pharming Group Product and Services
2.3.5 Pharming Group Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 KalVista Pharmaceuticals
2.4.1 KalVista Pharmaceuticals Details
2.4.2 KalVista Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 KalVista Pharmaceuticals SWOT Analysis
2.4.4 KalVista Pharmaceuticals Product and Services
2.4.5 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shire plc (Takeda Pharmaceutical Company Limited)
2.5.1 Shire plc (Takeda Pharmaceutical Company Limited) Details
2.5.2 Shire plc (Takeda Pharmaceutical Company Limited) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shire plc (Takeda Pharmaceutical Company Limited) SWOT Analysis
2.5.4 Shire plc (Takeda Pharmaceutical Company Limited) Product and Services
2.5.5 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioCryst Pharmaceuticals
2.6.1 BioCryst Pharmaceuticals Details
2.6.2 BioCryst Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioCryst Pharmaceuticals SWOT Analysis
2.6.4 BioCryst Pharmaceuticals Product and Services
2.6.5 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Attune Pharmaceuticals
2.7.1 Attune Pharmaceuticals Details
2.7.2 Attune Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Attune Pharmaceuticals SWOT Analysis
2.7.4 Attune Pharmaceuticals Product and Services
2.7.5 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Hereditary Angioedema Treatment Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Hereditary Angioedema Treatment Manufacturer Market Share in 2019
3.3.2 Top 6 Hereditary Angioedema Treatment Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Hereditary Angioedema Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Hereditary Angioedema Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Regions (2015-2020)
4.2 North America Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
4.3 Europe Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
4.5 South America Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Hereditary Angioedema Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Hereditary Angioedema Treatment Sales and Market Share by Country (2015-2020)
5.1.2 North America Hereditary Angioedema Treatment Revenue and Market Share by Country (2015-2020)
5.2 United States Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
5.3 Canada Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
5.4 Mexico Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Hereditary Angioedema Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Hereditary Angioedema Treatment Sales and Market Share by Country (2015-2020)
6.1.2 Europe Hereditary Angioedema Treatment Revenue and Market Share by Country (2015-2020)
6.2 Germany Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
6.3 UK Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
6.4 France Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
6.5 Russia Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
6.6 Italy Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Hereditary Angioedema Treatment Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Hereditary Angioedema Treatment Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Hereditary Angioedema Treatment Revenue and Market Share by Regions (2015-2020)
7.2 China Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
7.3 Japan Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
7.4 Korea Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
7.5 India Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
7.7 Australia Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Hereditary Angioedema Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Hereditary Angioedema Treatment Sales and Market Share by Country (2015-2020)
8.1.2 South America Hereditary Angioedema Treatment Revenue and Market Share by Country (2015-2020)
8.2 Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
8.3 Argentina Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Hereditary Angioedema Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Hereditary Angioedema Treatment Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Hereditary Angioedema Treatment Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
9.3 Turkey Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
9.4 Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
9.5 South Africa Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Hereditary Angioedema Treatment Sales and Market Share by Type (2015-2020)
10.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Type (2015-2020)
10.3 Global Hereditary Angioedema Treatment Price by Type (2015-2020)
11 Global Hereditary Angioedema Treatment Market Segment by Application
11.1 Global Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
11.2 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2015-2020)
11.3 Global Hereditary Angioedema Treatment Price by Application (2015-2020)
12 Market Forecast
12.1 Global Hereditary Angioedema Treatment Sales, Revenue and Growth Rate (2021-2025)
12.2 Hereditary Angioedema Treatment Market Forecast by Regions (2021-2025)
12.2.1 North America Hereditary Angioedema Treatment Market Forecast (2021-2025)
12.2.2 Europe Hereditary Angioedema Treatment Market Forecast (2021-2025)
12.2.3 Asia-Pacific Hereditary Angioedema Treatment Market Forecast (2021-2025)
12.2.4 South America Hereditary Angioedema Treatment Market Forecast (2021-2025)
12.2.5 Middle East & Africa Hereditary Angioedema Treatment Market Forecast (2021-2025)
12.3 Hereditary Angioedema Treatment Market Forecast by Type (2021-2025)
12.3.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2021-2025)
12.3.2 Global Hereditary Angioedema Treatment Market Share Forecast by Type (2021-2025)
12.4 Hereditary Angioedema Treatment Market Forecast by Application (2021-2025)
12.4.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2021-2025)
12.4.2 Global Hereditary Angioedema Treatment Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Hereditary Angioedema Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hereditary Angioedema Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. CSL Basic Information, Manufacturing Base and Competitors
Table 8. CSL Hereditary Angioedema Treatment Major Business
Table 9. CSL Hereditary Angioedema Treatment Total Revenue (USD Million) (2017-2018)
Table 10. CSL SWOT Analysis
Table 11. CSL Hereditary Angioedema Treatment Product and Services
Table 12. CSL Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Ionis Pharmaceuticals Hereditary Angioedema Treatment Major Business
Table 15. Ionis Pharmaceuticals Hereditary Angioedema Treatment Total Revenue (USD Million) (2017-2018)
Table 16. Ionis Pharmaceuticals SWOT Analysis
Table 17. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product and Services
Table 18. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pharming Group Basic Information, Manufacturing Base and Competitors
Table 20. Pharming Group Hereditary Angioedema Treatment Major Business
Table 21. Pharming Group Hereditary Angioedema Treatment Total Revenue (USD Million) (2017-2018)
Table 22. Pharming Group SWOT Analysis
Table 23. Pharming Group Hereditary Angioedema Treatment Product and Services
Table 24. Pharming Group Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. KalVista Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 26. KalVista Pharmaceuticals Hereditary Angioedema Treatment Major Business
Table 27. KalVista Pharmaceuticals Hereditary Angioedema Treatment Total Revenue (USD Million) (2017-2018)
Table 28. KalVista Pharmaceuticals SWOT Analysis
Table 29. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product and Services
Table 30. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Shire plc (Takeda Pharmaceutical Company Limited) Basic Information, Manufacturing Base and Competitors
Table 32. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Major Business
Table 33. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Total Revenue (USD Million) (2017-2018)
Table 34. Shire plc (Takeda Pharmaceutical Company Limited) SWOT Analysis
Table 35. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product and Services
Table 36. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. BioCryst Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 38. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Major Business
Table 39. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Total Revenue (USD Million) (2017-2018)
Table 40. BioCryst Pharmaceuticals SWOT Analysis
Table 41. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product and Services
Table 42. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Attune Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Attune Pharmaceuticals Hereditary Angioedema Treatment Major Business
Table 45. Attune Pharmaceuticals Hereditary Angioedema Treatment Total Revenue (USD Million) (2017-2018)
Table 46. Attune Pharmaceuticals SWOT Analysis
Table 47. Attune Pharmaceuticals Hereditary Angioedema Treatment Product and Services
Table 48. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Hereditary Angioedema Treatment Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Hereditary Angioedema Treatment Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Hereditary Angioedema Treatment Sales by Regions (2015-2020) (K Units)
Table 52. Global Hereditary Angioedema Treatment Sales Market Share by Regions (2015-2020)
Table 53. Global Hereditary Angioedema Treatment Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Hereditary Angioedema Treatment Sales by Countries (2015-2020) (K Units)
Table 55. North America Hereditary Angioedema Treatment Sales Market Share by Countries (2015-2020)
Table 56. North America Hereditary Angioedema Treatment Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Hereditary Angioedema Treatment Revenue Market Share by Countries (2015-2020)
Table 58. Europe Hereditary Angioedema Treatment Sales by Countries (2015-2020) (K Units)
Table 59. Europe Hereditary Angioedema Treatment Sales Market Share by Countries (2015-2020)
Table 60. Europe Hereditary Angioedema Treatment Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Hereditary Angioedema Treatment Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Hereditary Angioedema Treatment Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Hereditary Angioedema Treatment Sales by Countries (2015-2020) (K Units)
Table 65. South America Hereditary Angioedema Treatment Sales Market Share by Countries (2015-2020)
Table 66. South America Hereditary Angioedema Treatment Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Hereditary Angioedema Treatment Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Hereditary Angioedema Treatment Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Hereditary Angioedema Treatment Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Hereditary Angioedema Treatment Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Hereditary Angioedema Treatment Revenue Market Share by Countries (2015-2020)
Table 72. Global Hereditary Angioedema Treatment Sales by Type (2015-2020) (K Units)
Table 73. Global Hereditary Angioedema Treatment Sales Share by Type (2015-2020)
Table 74. Global Hereditary Angioedema Treatment Revenue by Type (2015-2020) (USD Million)
Table 75. Global Hereditary Angioedema Treatment Revenue Share by Type (2015-2020)
Table 76. Global Hereditary Angioedema Treatment Sales by Application (2015-2020) (K Units)
Table 77. Global Hereditary Angioedema Treatment Sales Share by Application (2015-2020)
Table 78. Global Hereditary Angioedema Treatment Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Hereditary Angioedema Treatment Market Share Forecast by Regions (2021-2025)
Table 80. Global Hereditary Angioedema Treatment Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Hereditary Angioedema Treatment Market Share Forecast by Type (2021-2025)
Table 82. Global Hereditary Angioedema Treatment Sales Forecast by Application (2021-2025)
Table 83. Global Hereditary Angioedema Treatment Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Hereditary Angioedema Treatment Picture
Figure 2. Global Sales Market Share of Hereditary Angioedema Treatment by Type in 2019
Figure 3. C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Picture
Figure 4. Selective Bradykinin B2 Receptor Antagonists (Firazyr) Picture
Figure 5. Kallikrein Inhibitors (Kalbitor, Takhzyro) Picture
Figure 6. Others (Conventional Drugs, Pipeline Drugs) Picture
Figure 7. Hereditary Angioedema Treatment Sales Market Share by Application in 2018
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Others (online pharmacies, mail pharmacies) Picture
Figure 11. Global Hereditary Angioedema Treatment Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Hereditary Angioedema Treatment Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Hereditary Angioedema Treatment Sales Market Share by Manufacturer in 2019
Figure 32. Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Hereditary Angioedema Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Hereditary Angioedema Treatment Revenue Market Share by Regions (2015-2020)
Figure 39. Global Hereditary Angioedema Treatment Revenue Market Share by Regions in 2018
Figure 40. North America Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
Figure 41. Europe Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
Figure 43. South America Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020)
Figure 45. North America Hereditary Angioedema Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Hereditary Angioedema Treatment Sales Market Share by Countries (2015-2020)
Figure 47. North America Hereditary Angioedema Treatment Sales Market Share by Countries in 2018
Figure 48. North America Hereditary Angioedema Treatment Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Hereditary Angioedema Treatment Revenue Market Share by Countries in 2018
Figure 50. United States Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Hereditary Angioedema Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Hereditary Angioedema Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Hereditary Angioedema Treatment Revenue Market Share by Countries in 2019
Figure 56. Germany Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Hereditary Angioedema Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Hereditary Angioedema Treatment Revenue Market Share by Regions 2019
Figure 64. China Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Hereditary Angioedema Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Hereditary Angioedema Treatment Sales Market Share by Countries in 2019
Figure 71. South America Hereditary Angioedema Treatment Revenue Market Share by Countries in 2019
Figure 72. Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Hereditary Angioedema Treatment Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Hereditary Angioedema Treatment Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Hereditary Angioedema Treatment Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Hereditary Angioedema Treatment Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Hereditary Angioedema Treatment Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Hereditary Angioedema Treatment Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Hereditary Angioedema Treatment Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Hereditary Angioedema Treatment Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Hereditary Angioedema Treatment Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Hereditary Angioedema Treatment Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
乳がん治療薬の世界市場 2020年 Market Overview The global Breast Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cancer T…- 脳卒中治療薬の世界市場 2020年 Market Overview The global Stroke Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stroke Treatment Drugs…
- 瘢痕治療薬の世界市場 2020年 Market Overview The Scar Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 血漿タンパク質製品の世界市場 2020年 Market Overview The global Plasma Protein Products market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasma Protein Produc…
- レーバー遺伝性視神経症治療薬の世界市場 2020年 Market Overview The global Leber's Hereditary Optic Neuropathy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lebe…